RESEARCH ARTICLE

Prevalence of chronic kidney disease amongst motor park workers in Yenagoa metropolis: World Kidney day 2023

Ndu victor O, Ujah Terhide, Okpiri James, Egbi Godwin, Frank Opuolia, Elagha Ayabowei

Department of Internal Medicine, Federal Medical Centre, Yenagoa, Bayelsa State, Nigeria

Corresponding Author: Ndu victor o, Department of Internal Medicine, Federal Medical Centre, Yenagoa, Bayelsa State, Nigeria. E-mail: [email protected]

Received: July 06, 2023                                              Published: July 18, 2023

Citation: victor N. Prevalence of chronic kidney disease amongst motor park workers in Yenagoa metropolis: World Kidney day 2023. Int J Complement Intern Med. 2023;5(1):181–188. DOI: 10. 58349/IJCIM. 1. 5. 2023. 00128

Copyright: ©2023 Ndu. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially.

Background 

Chronic Kidney Disease have been observed to be of increasing prevalence worldwide and its associated escalating cost of care and overall impact on health can be daunting especially in low- and middle-income earning populations in Sub Saharan Africa. Risk factors for this condition should be sorted out for in these populations. 

Objective 

This study was done to obtain the prevalence of CKD and the associated risk factors among motor park workers in Yenagoa metropolis, South – South Nigeria. 

Method 

One hundred and forty-four (144) subjects; motor park workers aged 18 years and above were recruited for the study via simple random sampling. History was obtained via interviewer – administered structured questionnaire, then subjects were evaluated for anthropometry, urinalysis, random blood glucose and serum creatinine. The outcome was analyzed via descriptive statistics using version 25.0 of statistical Package for Social Sciences (SPSS) software. Ethical consent was obtained from Ethical board, Federal Medical Centre Yenagoa. 

Results 

The study consisted of 102 males and 42 females. The mean age of the subjects was 45.1±12.4 years. The prevalence of CKD in the study was 11.1%. The prevalence of CKD was statistically significant across various age group. Though the most prevalent risk factor of CKD in this study was the use of herbal medications and obesity but the use of herbal medications and hypertension were the most associated risk factor for the development of CKD. Others identified risk factors include cigarette smoking and diabetes.

References 

1. Adelekun TA, Akinsola A. Hypertension induced chronic renal failure: clinical features, management and prognosis. West Afri J Med. 1998;17:104–108. 

2. Beaglehole R, Yach D. Globalization and the prevention and control of non–communicable disease. The neglected chronic kidney disease of adult. Lancet. 2003;362:903–908. 

3. Atkins RC. The changing patterns of chronic kidney disease: the need to develop strategies for prevention relevant to different regions and Countries. Kidney Int Suppl. 2005;98:83–85. 

4. K/DOQI clinical practice guideline for chronic kidney disease: evaluation, classification, stratification. Part IV: Definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002;39:546–575. 

5. Arogundade FA, Barsoum RS. CKD prevention in sub– Saharan Africa: a call for government, non–government and community support. Am J Kidney Dis. 2008;51:515–523. 

6. Pugsley D, Norris KC, Garcia Garcia G. Global approaches for understanding the disproportionate burden of chronic kidney disease. Ethn Dis. 2009;19:1– 2. 

7. National Kidney Foundation. K/DOQI clinical practice guideline for chronic kidney disease: evaluation, classification and stratification. Am J Kid Dis. 2002;39:1–226. 

8. Baker LRL. Renal Disease In: Kumar P, Clark M. Clinical medicine, 4th edn. WB Saunders. Philadephia. 1999; 20:572–573. 

9. Kadiri S. Towards reducing the impact of chronic kidney disease. African Health. 2001;23:9–10. 

10. Kadiri S, Arijie A. Temporal variations and metrological factors in hospital admission of chronic renal failure in South–south Nigeria. West Afri J Med. 1999;18:49–51. 

11. EL Nahas M, Bello AK. Chronic Kidney Disease: the global challenge. Lancet. 2005;365:331–340. 

12. Barsoum RS, Francis MR. Spectrum of glomerulonephritis in Egypt. Saudi J Kidney Dis Transpl. 2000;11:421–429. 

13. Barsoum RS. Chronic Kidney disease in the developing world. N Engl J Med. 2009;354:997–999. 

14. Akinsola W, Odesanmi WO, Oguniyi JO. Diseases causing chronic renal failure in Nigeria: a prospective study of 100 cases. Afri J Med Sc. 1989;18:131–135. 

15. Onyemekeihia R. Renal osteodystrophy in Benin. A dissertation submitted to the National post graduate Medical College of Nigeria, Faculty of Internal Medicine. 2004. 

16. Sanusi AA, Arogundade FA, Oladigbo M. Prevalence and pattern of renal bone disease in end stage renal disease patients in Ile–Ife, Nigeria. West Afri J Med. 2010;29:75–80. 

17. Barsoum RS. Chronic kidney disease in developing world. N Engl J Med. 2006;354:997–999. 

18. K/DOQI. Clinical practice guideline on hypertension and anti hypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:1–290. 

19. Excell L, McDonald S. Method and location of dialysis pp 25–33. ANZDATA Registry Report 2004. Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia.